Logo image of AQNB

ALGONQUIN PWR & UTILITY - AQNCN 8.65912 07/01/2079 (AQNB) Stock Fundamental Analysis

USA - NYSE:AQNB - US0158578080

25.681 USD
-0.11 (-0.42%)
Last: 10/23/2025, 8:04:00 PM
Fundamental Rating

3

AQNB gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 25 industry peers in the Multi-Utilities industry. Both the profitability and financial health of AQNB have multiple concerns. AQNB is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

AQNB had positive earnings in the past year.
In the past year AQNB had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: AQNB reported negative net income in multiple years.
Each year in the past 5 years AQNB had a positive operating cash flow.
AQNB Yearly Net Income VS EBIT VS OCF VS FCFAQNB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B

1.2 Ratios

AQNB has a Return On Assets of -10.09%. This is amonst the worse of the industry: AQNB underperforms 96.00% of its industry peers.
AQNB has a worse Return On Equity (-29.51%) than 96.00% of its industry peers.
AQNB has a Return On Invested Capital of 3.00%. This is amonst the worse of the industry: AQNB underperforms 88.00% of its industry peers.
AQNB had an Average Return On Invested Capital over the past 3 years of 2.36%. This is in line with the industry average of 3.82%.
The 3 year average ROIC (2.36%) for AQNB is below the current ROIC(3.00%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -10.09%
ROE -29.51%
ROIC 3%
ROA(3y)-3.11%
ROA(5y)-0.39%
ROE(3y)-11.12%
ROE(5y)-2.83%
ROIC(3y)2.36%
ROIC(5y)2.31%
AQNB Yearly ROA, ROE, ROICAQNB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

With a Operating Margin value of 20.38%, AQNB perfoms like the industry average, outperforming 52.00% of the companies in the same industry.
In the last couple of years the Operating Margin of AQNB has declined.
Looking at the Gross Margin, with a value of 74.06%, AQNB is in the better half of the industry, outperforming 72.00% of the companies in the same industry.
In the last couple of years the Gross Margin of AQNB has remained more or less at the same level.
Industry RankSector Rank
OM 20.38%
PM (TTM) N/A
GM 74.06%
OM growth 3Y3.93%
OM growth 5Y-3.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.98%
GM growth 5Y0.16%
AQNB Yearly Profit, Operating, Gross MarginsAQNB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

3

2. Health

2.1 Basic Checks

AQNB has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, AQNB has more shares outstanding
AQNB has more shares outstanding than it did 5 years ago.
The debt/assets ratio for AQNB has been reduced compared to a year ago.
AQNB Yearly Shares OutstandingAQNB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
AQNB Yearly Total Debt VS Total AssetsAQNB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

Based on the Altman-Z score of 1.32, we must say that AQNB is in the distress zone and has some risk of bankruptcy.
AQNB's Altman-Z score of 1.32 is amongst the best of the industry. AQNB outperforms 92.00% of its industry peers.
AQNB has a Debt/Equity ratio of 1.29. This is a high value indicating a heavy dependency on external financing.
With a decent Debt to Equity ratio value of 1.29, AQNB is doing good in the industry, outperforming 68.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.29
Debt/FCF N/A
Altman-Z 1.32
ROIC/WACC0.43
WACC6.93%
AQNB Yearly LT Debt VS Equity VS FCFAQNB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

A Current Ratio of 1.09 indicates that AQNB should not have too much problems paying its short term obligations.
The Current ratio of AQNB (1.09) is better than 88.00% of its industry peers.
A Quick Ratio of 0.90 indicates that AQNB may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.90, AQNB belongs to the top of the industry, outperforming 88.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.09
Quick Ratio 0.9
AQNB Yearly Current Assets VS Current LiabilitesAQNB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

3

3. Growth

3.1 Past

The earnings per share for AQNB have decreased strongly by -36.00% in the last year.
The earnings per share for AQNB have been decreasing by -10.38% on average. This is quite bad
AQNB shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -25.45%.
The Revenue has been growing slightly by 7.38% on average over the past years.
EPS 1Y (TTM)-36%
EPS 3Y-19.53%
EPS 5Y-10.38%
EPS Q2Q%-55.56%
Revenue 1Y (TTM)-25.45%
Revenue growth 3Y0.49%
Revenue growth 5Y7.38%
Sales Q2Q%-11.83%

3.2 Future

Based on estimates for the next years, AQNB will show a small growth in Earnings Per Share. The EPS will grow by 4.09% on average per year.
AQNB is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.30% yearly.
EPS Next Y-14.99%
EPS Next 2Y-0.67%
EPS Next 3Y5.62%
EPS Next 5Y4.09%
Revenue Next Year-10.65%
Revenue Next 2Y-3.7%
Revenue Next 3Y-1.05%
Revenue Next 5Y2.3%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
AQNB Yearly Revenue VS EstimatesAQNB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B 2.5B
AQNB Yearly EPS VS EstimatesAQNB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.2 0.4 0.6

0

4. Valuation

4.1 Price/Earnings Ratio

AQNB is valuated quite expensively with a Price/Earnings ratio of 80.25.
92.00% of the companies in the same industry are cheaper than AQNB, based on the Price/Earnings ratio.
AQNB's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.67.
With a Price/Forward Earnings ratio of 70.35, AQNB can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, AQNB is valued expensively inside the industry as 96.00% of the companies are valued cheaper.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.33, AQNB is valued quite expensively.
Industry RankSector Rank
PE 80.25
Fwd PE 70.35
AQNB Price Earnings VS Forward Price EarningsAQNB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AQNB indicates a rather expensive valuation: AQNB more expensive than 96.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 29.07
AQNB Per share dataAQNB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-0.67%
EPS Next 3Y5.62%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 6.64%, AQNB is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.74, AQNB pays a better dividend. On top of this AQNB pays more dividend than 96.00% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.35, AQNB pays a better dividend.
Industry RankSector Rank
Dividend Yield 6.64%

5.2 History

The dividend of AQNB has a limited annual growth rate of 0.06%.
AQNB has been paying a dividend for over 5 years, so it has already some track record.
AQNB has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)0.06%
Div Incr Years1
Div Non Decr Years4
AQNB Yearly Dividends per shareAQNB Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

AQNB has negative earnings and hence a negative payout ratio. The dividend may be in danger.
The dividend of AQNB is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-17.76%
EPS Next 2Y-0.67%
EPS Next 3Y5.62%
AQNB Yearly Income VS Free CF VS DividendAQNB Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B

ALGONQUIN PWR & UTILITY - AQNCN 8.65912 07/01/2079

NYSE:AQNB (10/23/2025, 8:04:00 PM)

25.681

-0.11 (-0.42%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryMulti-Utilities
Earnings (Last)08-08 2025-08-08/bmo
Earnings (Next)11-07 2025-11-07
Inst Owners71.48%
Inst Owner ChangeN/A
Ins Owners0.05%
Ins Owner ChangeN/A
Market Cap19.72B
Revenue(TTM)2.38B
Net Income(TTM)-1381809000
Analysts68.33
Price Target22.54 (-12.23%)
Short Float %0%
Short Ratio0.44
Dividend
Industry RankSector Rank
Dividend Yield 6.64%
Yearly Dividend0.41
Dividend Growth(5Y)0.06%
DP-17.76%
Div Incr Years1
Div Non Decr Years4
Ex-Date09-15 2025-09-15 (0.5412)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)20.74%
Min EPS beat(2)-0.69%
Max EPS beat(2)42.17%
EPS beat(4)1
Avg EPS beat(4)0.15%
Min EPS beat(4)-25.74%
Max EPS beat(4)42.17%
EPS beat(8)3
Avg EPS beat(8)0.22%
EPS beat(12)4
Avg EPS beat(12)-3.83%
EPS beat(16)5
Avg EPS beat(16)-3.04%
Revenue beat(2)2
Avg Revenue beat(2)3.06%
Min Revenue beat(2)0.82%
Max Revenue beat(2)5.31%
Revenue beat(4)2
Avg Revenue beat(4)0.36%
Min Revenue beat(4)-4.61%
Max Revenue beat(4)5.31%
Revenue beat(8)3
Avg Revenue beat(8)-2.11%
Revenue beat(12)7
Avg Revenue beat(12)0.07%
Revenue beat(16)10
Avg Revenue beat(16)1.41%
PT rev (1m)0.17%
PT rev (3m)5.95%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-2.48%
EPS NY rev (1m)0.46%
EPS NY rev (3m)6.47%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.55%
Revenue NY rev (1m)0.46%
Revenue NY rev (3m)-0.95%
Valuation
Industry RankSector Rank
PE 80.25
Fwd PE 70.35
P/S 8.29
P/FCF N/A
P/OCF 44.71
P/B 4.21
P/tB 5.99
EV/EBITDA 29.07
EPS(TTM)0.32
EY1.25%
EPS(NY)0.37
Fwd EY1.42%
FCF(TTM)-0.55
FCFYN/A
OCF(TTM)0.57
OCFY2.24%
SpS3.1
BVpS6.1
TBVpS4.29
PEG (NY)N/A
PEG (5Y)N/A
Graham Number6.63
Profitability
Industry RankSector Rank
ROA -10.09%
ROE -29.51%
ROCE 3.8%
ROIC 3%
ROICexc 3.01%
ROICexgc 3.38%
OM 20.38%
PM (TTM) N/A
GM 74.06%
FCFM N/A
ROA(3y)-3.11%
ROA(5y)-0.39%
ROE(3y)-11.12%
ROE(5y)-2.83%
ROIC(3y)2.36%
ROIC(5y)2.31%
ROICexc(3y)2.37%
ROICexc(5y)2.33%
ROICexgc(3y)2.6%
ROICexgc(5y)2.56%
ROCE(3y)2.99%
ROCE(5y)2.93%
ROICexgc growth 3Y4.3%
ROICexgc growth 5Y-5.03%
ROICexc growth 3Y4.14%
ROICexc growth 5Y-4.63%
OM growth 3Y3.93%
OM growth 5Y-3.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.98%
GM growth 5Y0.16%
F-Score4
Asset Turnover0.17
Health
Industry RankSector Rank
Debt/Equity 1.29
Debt/FCF N/A
Debt/EBITDA 6.71
Cap/Depr 209.43%
Cap/Sales 36.33%
Interest Coverage 1.25
Cash Conversion 49.18%
Profit Quality N/A
Current Ratio 1.09
Quick Ratio 0.9
Altman-Z 1.32
F-Score4
WACC6.93%
ROIC/WACC0.43
Cap/Depr(3y)213.94%
Cap/Depr(5y)245.17%
Cap/Sales(3y)39.89%
Cap/Sales(5y)45.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-36%
EPS 3Y-19.53%
EPS 5Y-10.38%
EPS Q2Q%-55.56%
EPS Next Y-14.99%
EPS Next 2Y-0.67%
EPS Next 3Y5.62%
EPS Next 5Y4.09%
Revenue 1Y (TTM)-25.45%
Revenue growth 3Y0.49%
Revenue growth 5Y7.38%
Sales Q2Q%-11.83%
Revenue Next Year-10.65%
Revenue Next 2Y-3.7%
Revenue Next 3Y-1.05%
Revenue Next 5Y2.3%
EBIT growth 1Y-22.44%
EBIT growth 3Y4.45%
EBIT growth 5Y4.06%
EBIT Next Year40.67%
EBIT Next 3Y19.82%
EBIT Next 5YN/A
FCF growth 1Y-33.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-7.88%
OCF growth 3Y45.17%
OCF growth 5Y-4.65%